Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 January 2024 | Story Igno van Niekerk | Photo Igno van Niekerk
Tafadzwa Maramura
Dr Tafadzwa Maramura participated in a study on couplepreneurs and ways in which they influence their children to become better entrepreneurs.

After years of hard work, the lonely entrepreneur rode off into the sunset. No family. No one to share the lived experience with. The entrepreneurial journey can be a recipe for loneliness. However, it does not have to be, you can enjoy an entrepreneurial family that leaves a legacy.

Dr Tafadzwa C Maramura, Senior Lecturer in the Department of Public Administration and Management at the UFS participated in a study with Drs Eugine Maziriri (University of Johannesburg), Miston Mapuranga (University of Pretoria), Brighton Nyagadza (Marondera University of Agricultural Sciences) on couplepreneurs and ways in which they influence their children to become better entrepreneurs. The interinstitutional study drew on several fields of expertise and was a fresh addition to the research on access to water that Dr Maramura is doing.

Couplepreneurship is a concept that explains businesses owned and operated by married and/or cohabiting couples. According to Dr Maramura: “The development of couplepreneurship in South Africa as an emerging economy has led to increasing interest in the study of how kids are inspired and/or influenced by their parents towards starting their own and to participate in the already existing family enterprises.”

Nurturing entrepreneurial potential

Couplepreneurs are in a great position to raise kidpreneurs. Who better to listen to the heroic stories of how mom and dad started off with a big dream, growth mindsets, and steadfast commitment to building their business than their offspring? Like teaching a person how to fish rather than giving them fish, couplepreneurs do not hand their kids a business, they teach them how to run and grow a business.

Dr Maramura believes that nurturing an entrepreneurial potential is the result of “encouraging resilience, adaptability, and a willingness to embrace failure, even as a learning opportunity”. Combine this with an environment that promotes creativity, critical thinking, and problem-solving skills, and you have the recipe for a kidpreneur to become an entrepreneur. Now add more ingredients: parents who offer support, mentorship, and exposure to diverse experiences. Put it in the heated oven called business – and you have created the meal all entrepreneurs crave: Legacy.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept